Year |
Citation |
Score |
2015 |
Chrencik JE, Roth CB, Terakado M, Kurata H, Omi R, Kihara Y, Warshaviak D, Nakade S, Asmar-Rovira G, Mileni M, Mizuno H, Griffith MT, Rodgers C, Han GW, Velasquez J, et al. Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1. Cell. 161: 1633-43. PMID 26091040 DOI: 10.1016/J.Cell.2015.06.002 |
0.558 |
|
2012 |
Hall T, Shieh HS, Day JE, Caspers N, Chrencik JE, Williams JM, Pegg LE, Pauley AM, Moon AF, Krahn JM, Fischer DH, Kiefer JR, Tomasselli AG, Zack MD. Structure of human ADAM-8 catalytic domain complexed with batimastat. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 68: 616-21. PMID 22684055 DOI: 10.1107/S1744309112015618 |
0.37 |
|
2010 |
Chrencik JE, Patny A, Leung IK, Korniski B, Emmons TL, Hall T, Weinberg RA, Gormley JA, Williams JM, Day JE, Hirsch JL, Kiefer JR, Leone JW, Fischer HD, Sommers CD, et al. Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6. Journal of Molecular Biology. 400: 413-33. PMID 20478313 DOI: 10.1016/j.jmb.2010.05.020 |
0.381 |
|
2007 |
Chrencik JE, Brooun A, Recht MI, Nicola G, Davis LK, Abagyan R, Widmer H, Pasquale EB, Kuhn P. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition. The Journal of Biological Chemistry. 282: 36505-13. PMID 17897949 DOI: 10.1074/Jbc.M706340200 |
0.469 |
|
2007 |
Brooun A, Foster SA, Chrencik JE, Chien EYT, Kolatkar AR, Streiff M, Ramage P, Widmer H, Weckbecker G, Kuhn P. Remedial strategies in structural proteomics: Expression, purification, and crystallization of the Vav1/Rac1 complex Protein Expression and Purification. 53: 51-62. PMID 17275330 DOI: 10.1016/j.pep.2006.10.027 |
0.407 |
|
2006 |
Chrencik JE, Brooun A, Kraus ML, Recht MI, Kolatkar AR, Gye WH, Seifert JM, Widmer H, Auer M, Kuhn P. Structural and biophysical characterization of the EphB4·EphrinB2 protein-protein interaction and receptor specificity Journal of Biological Chemistry. 281: 28185-28192. PMID 16867992 DOI: 10.1074/jbc.M605766200 |
0.491 |
|
2006 |
Chrencik JE, Brooun A, Recht MI, Kraus ML, Koolpe M, Kolatkar AR, Bruce RH, Martiny-Baron G, Widmer H, Pasquale EB, Kuhn P. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity. Structure (London, England : 1993). 14: 321-30. PMID 16472751 DOI: 10.1016/j.str.2005.11.011 |
0.44 |
|
2005 |
Chrencik JE, Orans J, Moore LB, Xue Y, Peng L, Collins JL, Wisely GB, Lambert MH, Kliewer SA, Redinbo MR. Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. Molecular Endocrinology (Baltimore, Md.). 19: 1125-34. PMID 15705662 DOI: 10.1210/Me.2004-0346 |
0.301 |
|
2004 |
Chrencik JE, Staker BL, Burgin AB, Pourquier P, Pommier Y, Stewart L, Redinbo MR. Mechanisms of camptothecin resistance by human topoisomerase I mutations. Journal of Molecular Biology. 339: 773-84. PMID 15165849 DOI: 10.1016/J.Jmb.2004.03.077 |
0.536 |
|
2003 |
Chrencik JE, Burgin AB, Pommier Y, Stewart L, Redinbo MR. Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex. The Journal of Biological Chemistry. 278: 12461-6. PMID 12533542 DOI: 10.1074/Jbc.M212930200 |
0.513 |
|
Show low-probability matches. |